Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
5.96
1.31 (28.17%)
At close: Aug 15, 2025, 3:59 PM
5.60
-6.01%
After-hours: Aug 15, 2025, 07:58 PM EDT
Karyopharm Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 38.73M | 38.78M | 62.48M | 72.83M | 84.81M | 31.09M | 52.89M | 43.66M | 80.89M | 84.06M | 135.19M | 71.35M | 82.25M | 153.26M | 190.46M | 137.4M | 141.31M | 88.47M |
Short-Term Investments | 12.97M | 31.16M | 46.24M | 60.7M | 67.35M | 117.95M | 139.21M | 164.66M | 155.87M | 176.32M | 142.78M | 77.03M | 88.6M | 52.05M | 38.16M | 66.81M | 94.58M | 135.89M |
Long-Term Investments | 350K | 340K | 308K | 306K | 304K | 304K | 301K | 381K | 387K | n/a | 633K | 626K | 631K | 636K | 637K | 2M | 2.01M | 7.68M |
Other Long-Term Assets | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 1.33M | 875K | n/a | 634K | 23.41M | 45.14M | 4.9M | 7.8M | 44.93M | 639K | 639K | 718K |
Receivables | 32.93M | 35.24M | 30.77M | 31.78M | 37.99M | 31.08M | 26.96M | 37.92M | 32.28M | 35.2M | 47.09M | 27.45M | 23.48M | 24.99M | 22.5M | 18.75M | 17.89M | 17.84M |
Inventory | 4.99M | 4.77M | 4.74M | 4.67M | 3.48M | 2.77M | 3.04M | 3.1M | 3.67M | 3.83M | 4.22M | 4.25M | 3.47M | 3.87M | 4.11M | 3.94M | 3.9M | 3.11M |
Other Current Assets | 21.22M | 10.29M | 12.28M | 14.78M | 82.3M | 15.02M | 151.69M | 545K | 18.66M | 19.13M | 20.89M | 32.55M | 33.22M | 30.15M | 6.35M | 14.67M | 15.82M | 815K |
Total Current Assets | 97.87M | 120.24M | 156.49M | 184.75M | 208.54M | 198.37M | 233.92M | 263.22M | 291.38M | 318.54M | 326.75M | 177.53M | 242.45M | 276.53M | 258.1M | 241.58M | 273.5M | 255.51M |
Property-Plant & Equipment | 5.33M | 5.8M | 6.28M | 3.08M | 3.8M | 4.45M | 4.88M | 5.48M | 6.06M | 6.63M | 7.38M | 7.93M | 8.5M | 9.06M | 1.64M | 9.87M | 10.42M | 11M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 7.01M | 7.47M | 7.93M | 4.72M | 5.44M | 6.09M | 6.52M | 6.74M | 6.45M | 7.26M | 31.42M | 53.7M | 14.03M | 17.5M | 47.21M | 12.52M | 13.06M | 19.4M |
Total Assets | 104.88M | 127.71M | 164.42M | 189.48M | 213.98M | 204.46M | 240.44M | 269.96M | 297.83M | 325.8M | 358.17M | 231.24M | 256.48M | 294.03M | 305.31M | 254.09M | 286.57M | 274.91M |
Account Payables | 2.6M | 5.87M | 5.11M | 5.78M | 2.8M | 5.03M | 3.12M | 943K | 2.29M | 9.04M | 2.77M | 813K | 1.69M | 3.44M | 1.6M | 881K | 2.31M | 3.04M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51.81M | n/a | n/a | n/a | 56.37M | n/a | 69.12M | 64.7M | 53.21M | 55.61M |
Short-Term Debt | 1.38M | 24.46M | 24.43M | n/a | 3.54M | 3.42M | 3.31M | 3.19M | 3.08M | n/a | n/a | 2.77M | 2.62M | 2.46M | n/a | 2.16M | 2.08M | 2M |
Other Current Liabilities | 95.24M | 1.94M | 15.56M | 52.04M | -2.08M | -1.39M | 43.23M | -967K | -1.33M | 2.5M | 40.64M | -308K | -750K | -400K | 50.11M | -1.04M | -1.55M | -637K |
Total Current Liabilities | 99.22M | 90.37M | 92.26M | 61.49M | 57.62M | 65.34M | 69.48M | 62.08M | 58.93M | 61.55M | 65.91M | 61.76M | 62.54M | 66.34M | 73.72M | 68.87M | 58.12M | 62.01M |
Long-Term Debt | 93.42M | 154.83M | 162.95M | 190.59M | 191.13M | 171.13M | 170.92M | 170.7M | 170.5M | 170.31M | 170.1M | 169.89M | 169.69M | 169.49M | 169.29M | 169.09M | 168.9M | 168.7M |
Other Long-Term Liabilities | 12.59M | 8.41M | 15.01M | 23.54M | 22.91M | 2.58M | 978K | 1.43M | 135.15M | 133.8M | 132.72M | 133M | 133M | 133M | 133M | 132.48M | 132.48M | 73.09M |
Total Long-Term Liabilities | 244.59M | 243.22M | 258.17M | 287.63M | 288.5M | 308.07M | 307.17M | 308.28M | 310.15M | 309.42M | 374.83M | 371.52M | 310.27M | 310.77M | 384.98M | 311.2M | 311.58M | 252.54M |
Total Liabilities | 343.81M | 333.6M | 350.44M | 349.12M | 346.12M | 373.41M | 376.64M | 370.36M | 369.08M | 370.97M | 374.83M | 371.52M | 372.82M | 377.11M | 384.98M | 380.07M | 369.7M | 314.55M |
Total Debt | 94.8M | 186.7M | 194.52M | 194.26M | 195.63M | 176.44M | 177.02M | 177.56M | 178.08M | 178.59M | 172.98M | 172.66M | 179.89M | 180.24M | 169.29M | 180.89M | 181.18M | 181.45M |
Common Stock | 4.33M | 13K | 13K | 13K | 13K | 12K | 12K | 12K | 12K | 12K | 12K | 8K | 8K | 8K | 8K | 8K | 8K | 8K |
Retained Earnings | -1.62B | -1.59B | -1.56B | -1.53B | -1.5B | -1.52B | -1.49B | -1.45B | -1.41B | -1.38B | -1.34B | -1.31B | -1.27B | -1.22B | -1.18B | -1.22B | -1.17B | -1.11B |
Comprehensive Income | -251K | -321K | -356K | -222K | -605K | -518K | -161K | -742K | -783K | -419K | -638K | -752K | -538K | 87K | 191K | 372K | 196K | 301K |
Shareholders Equity | -238.93M | -205.88M | -186.02M | -159.65M | -132.14M | -168.96M | -136.21M | -100.4M | -71.25M | -45.17M | -16.66M | -140.28M | -116.34M | -83.08M | -79.67M | -125.98M | -83.13M | -39.64M |
Total Investments | 13.32M | 31.16M | 46.24M | 61M | 67.65M | 118.25M | 139.51M | 164.66M | 155.87M | 176.32M | 142.78M | 77.03M | 88.6M | 52.05M | 38.16M | 68.82M | 96.59M | 143.57M |